APA (7th ed.) Citation

Lacquaniti, A., Gargano, R., Campo, S., Tocco, T. C. d., Schifilliti, S., & Monardo, P. (2023). The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis. MDPI AG.

Chicago Style (17th ed.) Citation

Lacquaniti, Antonio, Romana Gargano, Susanna Campo, Teresa Casuscelli di Tocco, Silvia Schifilliti, and Paolo Monardo. The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis. MDPI AG, 2023.

MLA (9th ed.) Citation

Lacquaniti, Antonio, et al. The Switch from Ferric Gluconate to Ferric Carboxymaltose in Hemodialysis Patients Acts on Iron Metabolism, Erythropoietin, and Costs: A Retrospective Analysis. MDPI AG, 2023.